STK11 and lung carcinoma: Sun et al. [134] demonstrated that high-dose ascorbic acid in lung cancers with primary resistance to immunotherapy and LKB1 deficiency can markedly increase intracellular ROS levels, thereby inducing pyroptosis of lung cancer cells, promoting DC maturation, and enhancing recruitment and proliferation of T cells.